Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Clinical trial NCT03284255 · UNKNOWN

Trial details

NCT number: NCT03284255
Sponsor: Shanghai Bio-heart Biological Technology Co., Ltd.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Coronary Artery Disease Antineoplastic Agents

Start date: 2017-09-11
Primary completion: 2020-08-30
Enrollment: 431

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.